Ionis Pharmaceuticals Inc (IONS) Profitability Comparisons, Net Margin, Gross Margin, Tax rate, Cash Flow Margin Comparisons - CSIMarket
CSIMarket
 


Ionis Pharmaceuticals Inc   (NASDAQ: IONS)

Ionis Pharmaceuticals Inc Profitability Comparisons

Select each Category to receive further Information




IONS Profitability Ratio

Company Industry Sector S&P 500
Gross Profit Margin (Q2 MRQ) 98.98 % 70.86 % 67.38 % 46.15 %
Gross Margin (Q2 TTM) 43.47 % 71.39 % 67.8 % 46.36 %
Gross Profit Margin 5 Yr. Avg. 98.4 % 67.81 % 65.55 % 48.95 %
EBITDA Margin (Q2 MRQ) -40.1 % 21.18 % 18.45 % 20.46 %
EBITDA Margin (Q2 TTM) -4.26 % 25.13 % 20.78 % 20.1 %
EBITDA Margin 5 Yr. Avg. --43.24 % 31.44 % 23.69 % 23.03 %
Operating Margin (Q2 MRQ) -38.18 % 17.04 % 16.52 % 16.05 %
Operating Margin (Q2 TTM) -25.17 % 20.45 % 17.83 % 16.34 %
Operating Margin 5 Yr. Avg. --57.61 % 15.37 % 14.33 % 19.26 %
Pre-Tax Profit Margin (Q2 MRQ) -42.31 % 13.42 % 10.72 % 13.96 %
Pre-Tax Profit Margin (Q2 TTM) -7.03 % 16.68 % 12.68 % 13.09 %
Pre-Tax Profit Margin 5 Yr. Avg. - 12.98 % 10.37 % 13.52 %
Net Margin (Q2 MRQ) -42.79 % 9.91 % 8.02 % 11.42 %
Net Margin (Q2 TTM) -26.77 % 13.16 % 9.86 % 10.76 %
Net Margin 5 Yr. Avg. - 5.79 % 6.08 % 10.8 %



Business Segment Profit Margin
 
TRYNGOLZA Sales
  Explore TRYNGOLZA Sales Segment  -
DAWNZERA Sales
  Explore DAWNZERA Sales Segment  -
SPINRAZA Royalties
  Explore SPINRAZA Royalties Segment  -
Other Royalties
  Explore Other Royalties Segment  -
Royalty
  Explore Royalty Segment  -
Collaborative Agreement Revenue
  Explore Collaborative Agreement Revenue Segment  -
WAINUA Joint Development Revenue
  Explore WAINUA Joint Development Revenue Segment  -
Research and Development Revenue
  Explore Research and Development Revenue Segment  -
Otsuka
  Explore Otsuka Segment  -
Ionis Operations
  Explore Ionis Operations Segment  -
Product
  Explore Product Segment  -
Commercial
  Explore Commercial Segment  -
Tryngolza
  Explore Tryngolza Segment  -
Salanersen
  Explore Salanersen Segment  -
Zilganersen
  Explore Zilganersen Segment  -
 

Company's Cashflow Profitability & Other



Profitability Ratios Company Industry Sector S&P 500
Free Cash Flow Margin (Q2 MRQ) 204.25 % -0.01 % 0.22 % 1.39 %
Free Cash Flow Margin (Q2 TTM) -24.98 % 17.47 % 13.83 % 9.08 %
Free Cash Flow Margin 5 Yr. Avg. - 19.28 % 14.86 % 15.58 %
Net Cash Flow Margin (Q2 MRQ) 0 % 0.02 % -0.02 % 0.13 %
Net Cash Flow Margin (Q2 TTM) -17.01 % -0.36 % 0.15 % 1.85 %
Net Cash Flow Margin 5 Yr. Avg. - 4.38 % 3.16 % 6.44 %
Effective Tax Rate (Q2 MRQ) -1.11 % 25.94 % 25.04 % 18.8 %
Effective Tax Rate (Q2 TTM) -1.78 % 21.36 % 23 % 19.44 %
Effective Tax Rate 5 Yr. Avg. - 15.08 % 20.51 % 19.76 %
Note
To view Detail Information & Trends click on Individual Category.
To see Industry, Sector or S&P 500 Performance, click on each Category respectivly, on the top of the Table.

For explanation of terms visit: Glossary
 




Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.